|

Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis

RECRUITINGPhase 3Sponsored by Cristian Ichim
Actively Recruiting
PhasePhase 3
SponsorCristian Ichim
Started2023-02-15
Est. completion2025-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06478602

Summary

The study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of liver cirrhosis according to current protocols.
* Conscious and cooperative adult patients.

Exclusion Criteria:

* Patients with hemodynamic and/or respiratory instability.
* Patients with contraindications for colonoscopy or fecal transplantation.
* Patients with acute or chronic infections with HIV, Tuberculosis, MDR Enterobacteria, CMV, parasites, fungi.
* Associated oncological pathology.
* Patients with other causes of severe immunodeficiencies.
* Lack of compliance with the conditions imposed by the research project.
* Patients who do not sign the informed consent.

Conditions2

Liver CirrhosisLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.